Research · head to head
Form Bio vs Medidata Rave
Form Bio
Research
Computational platform for cell and gene therapy design and manufacturability
- From
- On request
- Rated
- -
Medidata Rave
Research
Electronic data capture for regulated clinical trials, sold only through a sales process
- From
- On request
- Rated
- -
The short version
- Each has a real cost: Form Bio the company has pivoted twice since spinning out of Colossal Biosciences in 2022, from general computational life sciences to cell and gene therapy and then to AAV manufacturability, so any evaluation more than a year old describes a product that is no longer the commercial focus.; Medidata Rave no pricing is published at all, so a first time sponsor cannot budget a study without entering a sales process and usually cannot benchmark the quote against anything.
- They diverge on capability: Form Bio covers FormManufacturing, Medidata Rave covers Case report form design.
- Prices and features above were last checked on 31 August 2026.
Where they differ
Only the attributes on which Form Bio and Medidata Rave actually diverge.
| Attribute | Form Bio | Medidata Rave |
|---|---|---|
| Platforms | Web, Cloud | Web |
Identical on both: starting price (On request), pricing model (quote), free tier (No), user rating (Not yet rated), category (Research).
What each one covers
Drawn from each product's published feature list. An absence here means we hold no record of it - not that the product lacks it.
Only in Form Bio
- FormManufacturing
- Payload design optimisation
- Genome integrity analysis
- Manufacturability prediction
- In silico workflows
- Scale-up monitoring
- Cell and gene therapy focus
- Collaboration
Only in Medidata Rave
- Case report form design
- Edit checks and queries
- Part 11 audit trail
- Rave Lite
- Coding and safety
- Platform integrations
What people use each for
The jobs each tool is most often brought in to do.
Form Bio
- A gene therapy developer discovering manufacturability problems with an AAV construct late in process development and wanting to move that analysis earliernot Medidata Rave
- A biotech comparing several candidate payload designs in silico before committing to expensive production runsnot Medidata Rave
- A CDMO characterising what a client construct actually produces against what was specifiednot Medidata Rave
- A programme team needing genome integrity evidence to support regulatory conversations about product consistencynot Medidata Rave
Medidata Rave
- A sponsor running a registrational Phase III study where inspection readiness and a validated audit trail are non negotiablenot Form Bio
- A biotech that wants its CRO to run data management and benefits from the CRO already having Rave trained staff and templatesnot Form Bio
- A sponsor standardising forms across a programme so that a global library is reused rather than each study being built from scratchnot Form Bio
- A device or Phase IV study where Rave Lite gives the same compliance posture at a lower configuration burdennot Form Bio
Where each one falls short
Documented limitations, not opinions. Every one is a constraint you would hit in normal use.
Form Bio
- The company has pivoted twice since spinning out of Colossal Biosciences in 2022, from general computational life sciences to cell and gene therapy and then to AAV manufacturability, so any evaluation more than a year old describes a product that is no longer the commercial focus.
- The current offering launched AAV-focused, so developers working in lentiviral, mRNA or cell therapy modalities are outside the scope the platform was built and validated for.
- No pricing is published and engagements are scoped per programme, which makes it impossible to size the commitment before entering a sales process.
- This is a young venture-funded company whose analyses feed regulatory-facing decisions, so continuity of the vendor over a multi-year development programme is a genuine diligence question rather than a formality.
- Predictive manufacturability models need real production data to be trustworthy, and the value depends on how much of that a young vendor has accumulated, which is difficult for a buyer to verify independently.
Medidata Rave
- No pricing is published at all, so a first time sponsor cannot budget a study without entering a sales process and usually cannot benchmark the quote against anything.
- Cost is dominated by study build rather than licence, and every protocol amendment that changes a form triggers billable rework, so a study with unstable protocols costs far more than the initial quote implied.
- Configuration requires trained specialists, so most sponsors cannot build a study in house and are dependent on Medidata professional services or a CRO, which lengthens startup.
- The system assumes a professional clinical data management function; a small sponsor without data managers will not operate it directly and will pay a CRO to do so.
- Deep use of the wider Medidata platform for randomisation, imaging and patient reported data creates commercial lock in, because moving EDC later means unpicking integrations that were bought as one bundle.
Pricing, plan by plan
Form Bio
On request- FormManufacturing$undefined/year
- Pricing only through a sales process
- Scoped per therapeutic programme rather than per seat
- AAV-focused offering at launch
Medidata Rave
On request- Medidata Rave EDC$undefined/year
- Priced per study through a sales process
- Study build and configuration charged separately from licence
- Mid study amendments generally billable
Which should you pick?
Choose Form Bio if
- You need formmanufacturing.
- You work on Web, Cloud.
- You also want payload design optimisation.
Choose Medidata Rave if
- You need case report form design.
- You also want edit checks and queries.
Questions people ask
- Is Form Bio or Medidata Rave better?
- Neither clearly leads. Form Bio starts at On request and Medidata Rave at On request, and user ratings are close enough to be indistinguishable. Choose on capability and platform support.
- Which is cheaper, Form Bio or Medidata Rave?
- Form Bio starts at On request and Medidata Rave at On request.
- Does Form Bio or Medidata Rave run on more platforms?
- Form Bio runs on Web, Cloud. Medidata Rave runs on Web.
- What is Form Bio best used for?
- Form Bio is most often used for a gene therapy developer discovering manufacturability problems with an aav construct late in process development and wanting to move that analysis earlier, a biotech comparing several candidate payload designs in silico before committing to expensive production runs, a cdmo characterising what a client construct actually produces against what was specified, a programme team needing genome integrity evidence to support regulatory conversations about product consistency. Of those, a gene therapy developer discovering manufacturability problems with an aav construct late in process development and wanting to move that analysis earlier and a biotech comparing several candidate payload designs in silico before committing to expensive production runs are not what Medidata Rave is typically brought in for.
- What can Form Bio do that Medidata Rave cannot?
- Form Bio covers FormManufacturing, Payload design optimisation, Genome integrity analysis, Manufacturability prediction. Medidata Rave covers Case report form design, Edit checks and queries, Part 11 audit trail, Rave Lite.
Answered from the vendors’ own pages
Form Bio: What does Form Bio sell now?
FormManufacturing, launched in 2026, an AAV-focused platform for predicting, optimising and monitoring manufacturability of genetic medicines from construct design through scale-up.
Medidata Rave: Who owns Medidata?
Dassault Systemes, which acquired Medidata in 2019. Rave is sold as part of the Dassault life sciences portfolio.
Form Bio: Is it still a general bioinformatics platform?
No. It has narrowed from broad computational life sciences tooling to cell and gene therapy, and within that to AAV.
Medidata Rave: How is Rave priced?
Per study, through a sales process. Nothing is published, and study build and amendments are charged separately from the licence.
Form Bio: Where did the company come from?
It spun out of Colossal Biosciences in 2022.
Medidata Rave: Is Rave validated out of the box?
Medidata supplies validation and qualification documentation, but the sponsor still owns study level user acceptance testing and its own validation evidence.
Form Bio: Is pricing published?
No. Engagements are scoped per programme through a sales process.
Medidata Rave: What is Rave Lite for?
Lower complexity studies, typically Phase I, Phase IV and medical device, where a full study build is not justified.
Related pages
More on Medidata Rave
Other head to heads
- Form Bio vs Benchling
- Form Bio vs DNAnexus
- Form Bio vs Dotmatics
- Form Bio vs Seven Bridges
- Form Bio vs Terra
- Form Bio vs OpenEye, Cadence Molecular Sciences
- Form Bio vs Schrodinger
- Form Bio vs Sapio Sciences
- Form Bio vs Mouseflow
- Form Bio vs Chemaxon
- Form Bio vs Labguru
- Form Bio vs Obsidian
- Form Bio vs Paperpile
- Form Bio vs Reduct
- Form Bio vs Remesh
- Form Bio vs Scispot
- Form Bio vs Castor EDC
- Form Bio vs REDCap
- Form Bio vs Thermo SampleManager LIMS
- Form Bio vs Greenphire
- Form Bio vs Genedata
- Form Bio vs LabWare
- Form Bio vs Suzy
- Form Bio vs Marvin
- Medidata Rave vs Benchling
- Medidata Rave vs DNAnexus
- Medidata Rave vs Dotmatics
- Medidata Rave vs Seven Bridges
- Medidata Rave vs Terra
- Medidata Rave vs OpenEye, Cadence Molecular Sciences
- Medidata Rave vs Schrodinger
- Medidata Rave vs Sapio Sciences
- Medidata Rave vs Mouseflow
- Medidata Rave vs Chemaxon
- Medidata Rave vs Labguru
- Medidata Rave vs Obsidian
- Medidata Rave vs Paperpile
- Medidata Rave vs Reduct
- Medidata Rave vs Remesh
- Medidata Rave vs Scispot
- Medidata Rave vs Castor EDC
- Medidata Rave vs REDCap
- Medidata Rave vs Thermo SampleManager LIMS
- Medidata Rave vs Greenphire
- Medidata Rave vs Genedata
- Medidata Rave vs LabWare
- Medidata Rave vs Suzy
- Medidata Rave vs Marvin